RNA
Avidity Biosciences Inc.
$69.83
-$0.02(-0.03%)
68
Overall
55
Value
91
Tech
60
Quality
Market Cap
$6.05B
Volume
4.96M
52W Range
$21.51 - $70.51
Target Price
$70.93
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | ||
| Total Revenue | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $51.1M | $127.4M | $188.1M | $245.2M | $389.8M | ||
| Research & Development | $37.6M | $101.2M | $150.4M | $191.0M | $303.6M | ||
| Research Expense | $37.6M | $101.2M | $150.4M | $191.0M | $303.6M | ||
| Selling, General & Administrative | $13.5M | $26.2M | $37.7M | $54.2M | $86.2M | ||
| General & Administrative Expenses | $13.5M | $26.2M | $37.7M | $54.2M | $86.2M | ||
| Salaries & Wages | -- | -- | $27.1M | $38.2M | $51.4M | ||
| Depreciation & Amortization | $400.0K | $600.0K | $1.4M | $2.1M | $2.8M | ||
| Depreciation & Amortization | $400.0K | $600.0K | $1.4M | $2.1M | $2.8M | ||
| Other Operating Expenses | $-446.0K | $-1.3M | $-2.6M | $-6.2M | $-11.1M | ||
| OPERATING INCOME | |||||||
| Operating income | $-44.3M | $-118.1M | $-178.9M | $-235.6M | $-378.9M | ||
| EBITDA | $-43.8M | $-117.4M | $-181.7M | $-213.0M | $-324.4M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $209.0K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-209.0K | -- | $-5.0M | $-24.0M | -- | ||
| Gain on Sale of Securities | $206.0K | $104.0K | $5.0M | $24.0M | $56.9M | ||
| Other Income/Expense | $-126.0K | $140.0K | $-57.0K | $-23.4M | $-56.6M | ||
| Other Special Charges | $-75.0K | $-62.0K | $-57.0K | $-594.0K | $-248.0K | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-44.1M | $-118.1M | $-185.8M | $-218.1M | $-330.5M | ||
| Pre-Tax Income | $-44.4M | $-118.2M | $-174.0M | $-212.2M | $-322.3M | ||
| INCOME TAX | |||||||
| Tax Provision | $-3.0M | $-7.9M | $-11.8M | $-5.9M | $-8.2M | ||
| NET INCOME | |||||||
| Net Income | $-44.4M | $-118.0M | $-174.0M | $-212.2M | $-322.3M | ||
| Net Income (Continuing Operations) | $-44.4M | $-118.0M | $-174.0M | $-212.2M | $-322.3M | ||
| Net Income (Discontinued Operations) | $-44.4M | $-118.0M | $-174.0M | $-212.2M | $-322.3M | ||
| Net Income (Common Stockholders) | $-44.4M | $-118.0M | $-174.0M | $-212.2M | $-322.3M | ||
| Normalized Income | -- | -- | -- | -- | $-330.5M | ||
| TOTALS | |||||||
| Total Expenses | $51.1M | $127.4M | $188.1M | $245.2M | $389.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $21.7M | $41.4M | $52.2M | $73.0M | $111.6M | ||
| Average Shares Outstanding (Diluted) | $21.7M | $41.4M | $52.2M | $73.0M | $111.6M | ||
| Shares Outstanding | $37.6M | $47.8M | $70.8M | $128.7M | $120.2M | ||
| Basic EPS | $-2.05 | $-2.85 | $-3.34 | $-2.91 | $-2.89 | ||
| Basic EPS (Continuing Operations) | $-2.05 | $-2.85 | $-3.34 | $-2.91 | $-2.89 | ||
| Diluted EPS | $-2.05 | $-2.85 | $-3.34 | $-2.91 | $-2.89 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-3.34 | $-2.91 | $-2.89 | ||
| OTHER METRICS | |||||||
| Other Gand A | $13.5M | $26.2M | $37.7M | $54.2M | $86.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $69.83 | -0.0% | 4.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avidity Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW